Immutep 8-K/A Changes in Registrant's Certifying Accountant

EXHIBIT 16.1

	Deloitte & Touche LLP 555 E. Wells Street, Suite 1400
	Milwaukee, WI 53202-3824
	USA
	Tel: +1 414 271 3000
	www.deloitte.com

March 6, 2009

Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561

Dear Sirs/Madams:

We have read Item 4 of Immtech Pharmaceuticals, Inc.’s Form 8-K/A dated March 6, 2009, and have the following comments:

1.	We agree with the statements made in the first sentence of paragraph one and the entire second, third and fourth paragraphs of Item 4.01(a).
2.	We have no basis in which to agree or disagree with the statements made in the second sentence of the first paragraph of Item 4.01(a) or the two paragraphs included in Item 4.01(b).

Yours truly,

/s/ Deloitte & Touche LLP

Member of

Deloitte Touche Tohmatsu